The largest database of trusted experimental protocols

Recombinant human tgf β

Manufactured by Merck Group
Sourced in Germany

Recombinant human TGF-β is a laboratory reagent produced using recombinant DNA technology. It is a member of the transforming growth factor beta protein family. The core function of this product is to serve as a signaling molecule in various cellular processes.

Automatically generated - may contain errors

3 protocols using recombinant human tgf β

1

TGF-β Stimulation of LX-2 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
For TGF-β stimulation experiments LX-2 cells were seeded in 6-well plates at a density of 2–3 × 105 cells per well. Cells were serum starved overnight and transfected with miR-25 or control mimics, vs. miR-25 or control antagomirs, respectively, as described above. One day post transfection cells were treated with recombinant human TGF-β (5 ng/ml; Sigma) or an equal amount of phosphate-buffered saline (PBS) as control in serum-free medium. Cells were lysed after 6 h for subsequent protein analysis or after 24 h for RNA isolation.
+ Open protocol
+ Expand
2

Rat Hepatic Cell Line Response to TGF-β Stimulation

Check if the same lab product or an alternative is used in the 5 most similar protocols
The HSC-T6 immortalized rat cell line (Tumor Cell Bank of Chinese Academy of Medical Sciences, Beijing, China) was cultured in Dulbecco's modified Eagle's medium (Gibco; Thermo Fisher Scientific, Inc., Waltham, MA, USA) supplemented with 10% (v/v) fetal bovine serum (FBS; Gibco; Thermo Fisher Scientific, Inc.), 100 IU/ml penicillin and 100 µg/ml streptomycin (Beijing Suolaibao Biotechnology Co., Ltd., Beijing, China). Cells were incubated at 37°C in a humidified atmosphere containing 5% CO2. All experiments were carried out 24 h after the cells were seeded.
Cells were divided into two groups: The control group and the transforming growth factor (TGF)-β group. Recombinant human TGF-β (Sigma -Aldrich; Merck Millipore, Darmstadt, Germany) was used, since it is a major fibrogenic mediator in the liver (13 (link),14 (link)). TGF-β was administered to the cultured cells at 0, 1, 2, 5, 10 and 20 ng/ml for 0, 1, 3, 6, 12, 24 and 48 h. Cells were exposed to starvation conditions using FBS-free medium for 24 h prior to treatment with Recombinant human TGF-β.
+ Open protocol
+ Expand
3

Marilyn Induced Treg Cells Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Bone marrow dendritic cells (BMDC) were generated as previously described.34 (link) Marilyn induced Treg (iTreg) cells were obtained from naive Rag2–/– Marilyn spleen cells (5 × 105 cells/ml) cultured with BMDC (105 cells/ml), HY-AbDby peptide (10 nm), recombinant human TGF-β (2 ng/ml) and retinoic acid (1 μm, Sigma, St Louis, MO) for 5 days. Live cells were recovered on a gradient density (Lympholyte, Cedarlane Laboratories, Burlington, ON, Canada). Staining indicated ≥ 70% Foxp-3+ cells. Fresh BMDC (106 cells/ml) were co-cultured with iTreg cells (106 cells/ml) in the presence or absence of HY-AbDby peptide (1 nm) for 48 hr.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!